Previous close | 0.9000 |
Open | N/A |
Bid | 0.8000 |
Ask | 2.6500 |
Strike | 370.00 |
Expiry date | 2024-05-17 |
Day's range | 0.9000 - 0.9000 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Danaher Corporation (DHR) and Abbott Laboratories (ABT), as well as a micro-cap stock Ark Restaurants Corp. (ARKR).
On May 16, 2024, Rainer Blair, President & CEO of Danaher Corp (NYSE:DHR), executed a sale of 9,005 shares of the company.
Danaher (DHR) gains from strength in academic and applied markets, Abcam buyout and pro-investor policies. However, softness in its Biotechnology unit is concerning.